Evonik’s latest layoffs are tied to discontinuing production of keto acids in Hanau, Germany, by the end of next year.

Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market.

The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...

As companies roll out data showing the power and improved safety profile of antibodies that target two antigens, analysts say ...